These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 11061352)
1. In pursuit of the prevention of breast cancer. Yardley DA Am J Med Sci; 2000 Oct; 320(4):263-72. PubMed ID: 11061352 [No Abstract] [Full Text] [Related]
2. Tamoxifen prevention of breast cancer: an instance of the fingerpost. Lippman SM; Brown PH J Natl Cancer Inst; 1999 Nov; 91(21):1809-19. PubMed ID: 10547388 [No Abstract] [Full Text] [Related]
3. Breast cancer chemoprevention: current status and future directions. Wickerham DL; Tan-Chiu E Semin Oncol; 2001 Jun; 28(3):253-9. PubMed ID: 11402435 [TBL] [Abstract][Full Text] [Related]
4. Future possibilities in the prevention of breast cancer: breast cancer prevention trials. Cuzick J Breast Cancer Res; 2000; 2(4):258-63. PubMed ID: 11250718 [TBL] [Abstract][Full Text] [Related]
5. The prevention of breast cancer: an overview. Leris C; Mokbel K Curr Med Res Opin; 2001; 16(4):252-7. PubMed ID: 11268709 [TBL] [Abstract][Full Text] [Related]
6. Recruitment of women into trials. Benson JR Lancet; 2002 Jan; 359(9301):164. PubMed ID: 11809281 [No Abstract] [Full Text] [Related]
7. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. McPherson K; Steel CM; Dixon JM BMJ; 2000 Sep; 321(7261):624-8. PubMed ID: 10977847 [No Abstract] [Full Text] [Related]
9. Chemoprevention with antiestrogens: the beginning of the end for breast cancer. Daniel G. Miller Lecture. Jordan VC Ann N Y Acad Sci; 2001 Dec; 952():60-72. PubMed ID: 11795444 [TBL] [Abstract][Full Text] [Related]
10. The role of selective estrogen receptor modulators in the prevention of breast cancer: comparison of the clinical trials. Martino S; Costantino J; McNabb M; Mershon J; Bryant K; Powles T; Secrest RJ Oncologist; 2004; 9(2):116-25. PubMed ID: 15047916 [TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of breast cancer. Thomsen A; Kolesar JM Am J Health Syst Pharm; 2008 Dec; 65(23):2221-8. PubMed ID: 19020189 [TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene. Chlebowski RT; Collyar DE; Somerfield MR; Pfister DG J Clin Oncol; 1999 Jun; 17(6):1939-55. PubMed ID: 10561236 [TBL] [Abstract][Full Text] [Related]
13. STAR: first-year recruitment efforts set brisk pace for future. CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236 [No Abstract] [Full Text] [Related]
14. Preventive therapy for breast cancer: a consensus statement. Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069 [TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Risk-Reducing Medications. Graham D; DiNome ML; Ganz PA JAMA; 2020 Jul; 324(3):310. PubMed ID: 32692388 [No Abstract] [Full Text] [Related]
16. [Breakthrough in breast cancer chemoprevention]. Kahán Z; Thurzó L Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784 [TBL] [Abstract][Full Text] [Related]
17. Is low-dose tamoxifen useful for the treatment and prevention of breast cancer? Wu K; Brown P J Natl Cancer Inst; 2003 Jun; 95(11):766-7. PubMed ID: 12783921 [No Abstract] [Full Text] [Related]
18. [Prevention of breast cancer--what are the latest developments?]. Nahum R; Kaplan B; Ben-Rafael Z Harefuah; 2001 Jan; 140(1):32-4. PubMed ID: 11242896 [No Abstract] [Full Text] [Related]
19. Chemoprevention of breast cancer: recommendations and rationale. U.S. Preventive Services Task Force Ann Intern Med; 2002 Jul; 137(1):56-8. PubMed ID: 12093249 [No Abstract] [Full Text] [Related]
20. Breast cancer chemoprevention. Mamounas EP Hematol Oncol Clin North Am; 2000 Jun; 14(3):727-38. PubMed ID: 11203331 [No Abstract] [Full Text] [Related] [Next] [New Search]